Natural history of hepatocellular carcinoma

Cancer Imaging

Volumn 5, Issue 1, 2005, Pages 85-88

  Colombo, Massimo ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Abdominal ultrasound; Alpha fetoprotein; Cirrhosis; Computed tomography; Hepatocellular carcinoma (HCC); Magnetic resonance

Indexed keywords

ARTICLE; DIAGNOSTIC IMAGING; DISEASE COURSE; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; PATHOPHYSIOLOGY; PROGNOSIS;

CARCINOMA, HEPATOCELLULAR; DIAGNOSTIC IMAGING; DISEASE PROGRESSION; HUMANS; LIVER NEOPLASMS; PROGNOSIS;

EID: 33645270580     PISSN: None     EISSN: 14707330     Source Type: Journal    
DOI: 10.1102/1470-7330.2005.0014     Document Type: Article

References (26)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94: 153-6.
2. Bruix J, Sherman M, Llovet JM et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference, Barcelona, September 15-17, 2000. J Hepatol 2001; 35: 421-30.
3. Bralet MP, Regimbeau JM, Pineau P et al. Hepatocellular carcinoma occurring in nonfibrotic liver: epidemiologic and histopathologic analysis of 80 French cases. Hepatology 2000; 32: 200-4.
4. Sell S. Cellular origin of hepatocellular carcinoma. Semin Cell Dev Biol 2002; 13: 419-24.
5. Kojiro M. Pathology of early hepatocellular carcinoma: progression from early to advanced. Hepatogastroenterology 1998; 45: 1203-5.
6. International Working Party. Terminology of nodular hepatocellular lesions. Hepatology 1995; 22: 983-93.
7. Kojiro M. The evolution of pathologic features of hepatocellular carcinoma. In: Viruses and liver cancer, Zuckerman AJ, Mushahwar IK, eds. Amsterdam: Elsevier, 2002: 113-22.
8. Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999; 19: 329-38.
9. The Cancer of the Liver Italian Program (CLIP) Investigators. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients. Hepatology 1998; 28: 751-5.
10. Leung TW, Tang AM, Zee B et al. Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients. Cancer 2002; 94: 1760-9.
11. Henderson JM, Sherman M, Tavill A et al. AHPBA/AJCC consensus conference on staging of hepatocellular carcinoma: consensus statement. HPB 2003; 5: 143-250.
12. Chevret S, Trinchet JC, Mathieu D et al. A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire. J Hepatol 1999; 31: 133-41.
13. Rabe C, Lenz M, Schmitz V et al. An independent evaluation of modern prognostic scores in a central European cohort of 120 patients with hepatocellular carcinoma. Eur J Gastroenterol Hepatol 2003; 15: 1305-15.
14. Colombo M, Sangiovanni A. The strategic role of staging in the treatment of HCC. Hepatology 2004; 39: 552-3.
15. Okazaki N, Yoshino M, Yoshida T et al. Evaluation of the prognosis for small hepatocellular carcinoma based on tumor volume doubling time. A preliminary report. Cancer 1989; 63: 2207-10.
16. Oka H, Tamori A, Kuroki T et al. Prospective study of α-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma. Hepatology 1994; 19: 61-6.
17. Colombo M, de Franchis R, Del Ninno E et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 1991; 325: 675-80.
18. Cottone M, Turri M, Caltagirone M et al. Screening for hepatocellular carcinoma in patients with Child's A cirrhosis: a 8 year prospective study by ultrasound and alphafetoprotein. J Hepatol 1994; 21: 1029-34.
19. Bolondi L, Sofia S, Siringo S et al. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut 2001; 48: 251-9.
20. Fasani P, Sangiovanni A, De Fazio C et al. High prevalence of multinodular hepatocellular carcinoma in patients with cirrhosis due to multiple etiological factors. Hepatology 1999; 29: 1704-7.
21. Kumada T, Nakano S, Takeda I et al. Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma. Hepatology 1997; 25: 87-92.
22. Franco D, Capussotti L, Smadja C et al. Resection of hepatocellular carcinomas. Results in 72 European patients with cirrhosis. Gastroenterology 1990; 98: 733-8.
23. Anthony PP. Primary carcinoma of the liver. A study of 282 cases in Ugandan Africans. J Pathol 1973; 110: 37-48.
24. Tsai TJ, Chau GY, Lui WY et al. Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma. Surgery 2000; 127: 603-8.
25. Mazzaferro V, Regalia E, Doci R et al. Liver transplantation for treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-9.
26. Sangiovanni A, Del Ninno E, Fasani P et al. Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. Gastroenterology 2004; 126: 1005-14.